Jeito Capital Co-Leads $156 Million Oversubscribed Series B Financing In Quell Therapeutics

Nov 29, 2021•over 3 years ago

Amount Raised

$156 Million

Round Type

series b

Paris

Description

Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics

Company Information

Company

Jeito

Location

Paris, Texas, United States

About

Jeito est un fonds biotechnologique de nouvelle génération dont l'approche est axée sur les avantages pour les patients et qui se concentre à la fois sur le financement d'innovations médicales révolutionnaires et sur la promotion d'un impact sociétal positif.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Jeito Capital Co-Leads $156 Million Oversubscribed Series B Financing In Quell Therapeutics

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information